Sartorius Stedim Biotech Stock

Equities

DIM

FR0013154002

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 11:38:39 2024-04-19 am EDT 5-day change 1st Jan Change
200.6 EUR -4.29% Intraday chart for Sartorius Stedim Biotech -19.95% -16.24%
Sales 2024 * 2.98B 3.17B Sales 2025 * 3.41B 3.63B Capitalization 19.52B 20.79B
Net income 2024 * 350M 373M Net income 2025 * 468M 499M EV / Sales 2024 * 7.37 x
Net Debt 2024 * 2.43B 2.59B Net Debt 2025 * 2.24B 2.39B EV / Sales 2025 * 6.39 x
P/E ratio 2024 *
55.6 x
P/E ratio 2025 *
39.1 x
Employees 10,493
Yield 2024 *
0.44%
Yield 2025 *
0.56%
Free-Float 31.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.29%
1 week-19.95%
Current month-24.10%
1 month-24.04%
3 months-9.35%
6 months+2.87%
Current year-16.24%
More quotes
1 week
195.40
Extreme 195.4
258.00
1 month
195.40
Extreme 195.4
281.00
Current year
195.40
Extreme 195.4
281.00
1 year
160.55
Extreme 160.55
287.80
3 years
160.55
Extreme 160.55
551.00
5 years
106.50
Extreme 106.5
551.00
10 years
20.00
Extreme 20
551.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 19-03-25
Chairman 59 07-06-28
Chief Tech/Sci/R&D Officer 59 09-04-28
Members of the board TitleAgeSince
Director/Board Member 62 07-06-28
Chairman 59 07-06-28
Director/Board Member 67 15-04-06
More insiders
Date Price Change Volume
24-04-19 200.6 -4.29% 169,509
24-04-18 209.6 -15.69% 299,152
24-04-17 248.6 -1.54% 50,723
24-04-16 252.5 -0.82% 43,785
24-04-15 254.6 +1.60% 39,906

Real-time Euronext Paris, April 19, 2024 at 11:38 am EDT

More quotes
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
200.6 EUR
Average target price
262.8 EUR
Spread / Average Target
+31.02%
Consensus